Cargando…

Safety and efficacy of Everolimus‐Eluting bioabsorbable Polymer‐Coated stent in patients with long coronary lesions: The EVOLVE 48 study

OBJECTIVES: The EVOLVE 48 study evaluated the safety and effectiveness of the SYNERGY 48 mm stent for the treatment of long lesions. BACKGROUND: Clinical evidence supporting the use of very long stents during percutaneous coronary intervention (PCI) is limited. The bioabsorbable polymer SYNERGY sten...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karmpaliotis, Dimitrios, Stoler, Robert, Walsh, Simon, El‐Jack, Seif, Potluri, Srinivasa, Moses, Jeffrey, Oldroyd, Keith, Banning, Adrian, Webster, Mark, Zaman, Azfar, Wu, Willis, Ahmed, Mudassar, Underwood, Paul, Allocco, Dominic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Coronary Artery Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545912/ https://www.ncbi.nlm.nih.gov/pubmed/34051049 http://dx.doi.org/10.1002/ccd.29798

Ejemplares similares

Five‐year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus‐eluting coronary stents with everolimus‐eluting bioresorbable vascular scaffolds
por: Schukraft, Sara, et al.
Publicado: (2021)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent
por: Toelg, Ralph, et al.
Publicado: (2020)

Comparison of neointimal coverage between ultrathin biodegradable polymer‐coated sirolimus‐eluting stents and durable polymer‐coated everolimus‐eluting stents: 6 months optical coherence tomography follow‐up from the TAXCO study
por: Abhyankar, Atul, et al.
Publicado: (2020)

Comparison of long‐term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus‐eluting stent or permanent polymer everolimus‐eluting stent: 5‐year results of the CENTURY II randomized clinical trial
por: Iñiguez, Andrés, et al.
Publicado: (2019)

Three‐year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus‐eluting stent in routine PCI in patients with diabetes mellitus—AIDA sub‐study
por: Kerkmeijer, Laura S.M., et al.
Publicado: (2020)

Cost‐effectiveness of percutaneous coronary intervention with cobalt‐chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta‐analysis of randomized trials
por: Ferko, Nicole, et al.
Publicado: (2016)

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model
por: Watt, Jonathan, et al.
Publicado: (2013)

Mechanical properties of the drug‐eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug‐eluting stent
por: Barkholt, Trine Ø., et al.
Publicado: (2019)

The relationship between re-endothelialization and endothelial function after DES implantation: Comparison between paclitaxcel eluting stent and zotarolims eluting stent
por: Murase, Suguru, et al.
Publicado: (2014)

One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis
por: Rozemeijer, Rik, et al.
Publicado: (2019)

Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality
por: Bawamia, Bilal R., et al.
Publicado: (2020)

Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual‐therapy CD34 antibody‐covered sirolimus‐eluting Combo stent and the sirolimus‐eluting Orsiro stent
por: Jakobsen, Lars, et al.
Publicado: (2022)

Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019)

Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus
por: Noman, Awsan, et al.
Publicado: (2016)

Bioresorbable vascular scaffolds versus conventional drug-eluting stents across time: a meta-analysis of randomised controlled trials
por: Jackson-Smith, Elliot, et al.
Publicado: (2022)

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
por: Petroni, Thibaut, et al.
Publicado: (2016)

Biological effect on drug distribution and vascular healing via paclitaxel‐coated balloon technology in drug eluting stent restenosis swine model
por: Li, Yan, et al.
Publicado: (2015)

A propensity matched comparison of return to work and quality of life after stenting or coronary artery bypass surgery
por: Maznyczka, Annette M, et al.
Publicado: (2016)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020)

Beta blockers versus calcium channel blockers for provocation of vasospastic angina after drug-eluting stent implantation: a multicentre prospective randomised trial
por: Sawano, Mitsuaki, et al.
Publicado: (2020)

Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?
por: Benenati, Stefano, et al.
Publicado: (2023)

Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention
por: Krenn, Lisa, et al.
Publicado: (2014)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019)

Drug-eluting stents in large coronary vessels improve both safety and efficacy compared with bare-metal stents in women: a pooled analysis of the BASKET-PROVE I and II trials
por: Bjerking, Louise Hougesen, et al.
Publicado: (2019)

Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial
por: De Filippo, Ovidio, et al.
Publicado: (2020)

Comparison of 6‐month vascular healing response after bioresorbable polymer versus durable polymer drug‐eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study
por: Noguchi, Masahiko, et al.
Publicado: (2021)

Final 5-Year Results in Randomized Japanese Patients Implanted With a Thin-Strut, Bioabsorbable, Polymer-Coated, Everolimus-Eluting SYNERGY Stent (From the EVOLVE II Study)
por: Kimura, Takeshi, et al.
Publicado: (2020)

Infarct size and left ventricular remodelling after preventive percutaneous coronary intervention
por: Mangion, Kenneth, et al.
Publicado: (2016)

Sex-based associations with microvascular injury and outcomes after ST-segment elevation myocardial infarction
por: Maznyczka, Annette Marie, et al.
Publicado: (2019)

Sex differences in procedural and clinical outcomes following rotational atherectomy
por: Ford, Thomas J., et al.
Publicado: (2019)

Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial
por: Hennigan, Barry, et al.
Publicado: (2020)

Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions
por: Sharma, Vinoda, et al.
Publicado: (2015)

Everolimus-eluting stents: update on current clinical studies
por: Allocco, Dominic J, et al.
Publicado: (2011)

Long-term Outcomes for Drug-eluting Balloons versus Drug-eluting Stents in the Treatment of Small Vessel Coronary Artery Disease: A Systematic Review and Meta-analysis
por: Murphy, Greg, et al.
Publicado: (2023)

Effects of Oral Testosterone Treatment on Myocardial Perfusion and Vascular Function in Men With Low Plasma Testosterone and Coronary Heart Disease
por: Webb, Carolyn M., et al.
Publicado: (2008)

Treatment of Heart Failure With Normal Ejection Fraction
por: Hamdani, Nazha, et al.
Publicado: (2010)

Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project
por: Quinn, Tom, et al.
Publicado: (2014)

The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation
por: Body, Richard, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_goqfr7q02g52641uq4s9pljk8e